Tivic Expands Intellectual Property Portfolio

New Biologics Patent Application Covers Potential Applicability of TLR5 Agonists to Improve Outcomes for Late-stage Cancer Therapies; Bioelectronic Patent Covers Optimized ncVNS Device Specifications FREMONT, Calif. – Tivic Health® Systems, Inc. (Nasdaq:...